Home

HOPA Ahead 2019
  • HOPA19_Central_1200X250.jpg

Upcoming Events


HOPA News

Check out the latest edition of HOPA News!

HOPA News Volume 15 issue 4

Latest Discussions

HOPA Bulletin

  • An attractive approach to liver cancer treatment is to bolster the body's own immune defenses. Now an international team involving A*STAR researchers has genetically engineered human T cells to endow them with both specificity against liver cancer cells in patients with Hepatitis B, and the potential for long-term antitumor efficacy.

Getting Started

Check out our user guide for further information.

Recent Shared Files

Connect With Us